Nanda Horeweg

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

Harry J. de Koning, Carlijn M. van der Aalst, Pim A. de Jong et al. · New England Journal of Medicine · 2020 · 3.3K citations · Full text

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

Alicia León‐Castillo, Stephanie M. de Boer, Melanie Powell et al. · Journal of Clinical Oncology · 2020 · 777 citations · Full text

Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening

Nanda Horeweg, Joost van Rosmalen, Marjolein A. Heuvelmans et al. · The Lancet Oncology · 2014 · 511 citations

Nelson Trial, Medical Imaging, Advanced Lung Disease +12

Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers

Nanda Horeweg, Ernst T. Scholten, Pim A. de Jong et al. · The Lancet Oncology · 2014 · 374 citations

Medical Imaging, Cancer Detection, Cancer Screening +11

Characteristics of Lung Cancers Detected by Computer Tomography Screening in the Randomized NELSON Trial

Nanda Horeweg, Carlijn M. van der Aalst, Erik Thunnissen et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 266 citations · Full text